Getting specialized: presynaptic and postsynaptic dopamine D2 receptors

Current Opinion in Pharmacology

Volumn 9, Issue 1, 2009, Pages 53-58

  De Mei, Claudia ^a   Ramos, Maria ^a   Iitaka, Chisato ^a   Borrelli, Emiliana ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; COCAINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; PHOSPHOPROTEIN DARPP 32; PROTEIN SERINE THREONINE KINASE;

BEHAVIOR; CELL ACTIVITY; COCAINE DEPENDENCE; CONDITIONING; DOPAMINERGIC NERVE CELL; DRUG ABUSE; DRUG DEPENDENCE; ENZYME ACTIVATION; HORMONE RELEASE; IN VIVO STUDY; LOCOMOTION; MOTOR ACTIVITY; NERVE CELL STIMULATION; NONHUMAN; PLACE PREFERENCE; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; REINFORCEMENT; REVIEW; REWARD; SIGNAL TRANSDUCTION;

ANIMALS; COCAINE; DOPAMINE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTATION; NEURONS; RECEPTORS, DOPAMINE D2; RECEPTORS, PRESYNAPTIC; REINFORCEMENT (PSYCHOLOGY); REWARD; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 59349089295     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2008.12.002     Document Type: Review

References (53)

1. Wise R.A. Forebrain substrates of reward and motivation. J Comp Neurol 493 (2005) 115-121
2. Di Chiara G., and Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7 (2007) 69-76
3. Koob G.F. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101 Suppl. 1 (2006) 23-30
4. Tan S., Hermann B., and Borrelli E. Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter. Int Rev Neurobiol 54 (2003) 145-197
5. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., and Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377 (1995) 424-428
6. Kelly M.A., Rubinstein M., Asa S.L., Zhang G., Saez C., Bunzow J.R., Allen R.G., Hnasko R., Ben-Jonathan N., Grandy D.K., and Low M.J. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19 (1997) 103-113
7. Jung M.Y., Skryabin B.V., Arai M., Abbondanzo S., Fu D., Brosius J., Robakis N.K., Polites H.G., Pintar J.E., and Schmauss C. Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors. Neuroscience 91 (1999) 911-924
8. Usiello A., Baik J.H., Rouge-Pont F., Picetti R., Dierich A., LeMeur M., Piazza P.V., and Borrelli E. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408 (2000) 199-203
9. Wang Y., Xu R., Sasaoka T., Tonegawa S., Kung M.P., and Sankoorikal E.B. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J Neurosci 20 (2000) 8305-8314
10. Bozzi Y., and Borrelli E. Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?. Trends Neurosci 29 (2006) 167-174
11. Nishi A., Snyder G.L., and Greengard P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci 17 (1997) 8147-8155
12. Bateup H.S., Svenningsson P., Kuroiwa M., Gong S., Nishi A., Heintz N., and Greengard P. Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci 11 (2008) 932-939
13. Fienberg A.A., Hiroi N., Mermelstein P.G., Song W., Snyder G.L., Nishi A., Cheramy A., O'Callaghan J.P., Miller D.B., Cole D.G., et al. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281 (1998) 838-842
14. Herve D., Le Moine C., Corvol J.C., Belluscio L., Ledent C., Fienberg A.A., Jaber M., Studler J.M., and Girault J.A. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci 21 (2001) 4390-4399
15. Lindgren N., Usiello A., Goiny M., Haycock J., Erbs E., Greengard P., Hokfelt T., Borrelli E., and Fisone G. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci U S A 100 (2003) 4305-4309
16. Senogles S.E. The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins. J Biol Chem 269 (1994) 23120-23127
17. Guiramand J., Montmayeur J.P., Ceraline J., Bhatia M., and Borrelli E. Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J Biol Chem 270 (1995) 7354-7358
18. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., and Caron M.G. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122 (2005) 261-273. This article identifies a novel G-protein-independent dopamine transduction pathway regulating AKT activity and mediated by D2-like receptors. Signaling to the AKT pathway are induced by the formation of a macromolecular complex containing AKT, β-arrestin2 and the protein phosphatase PP2A. This is the first study showing a connection between dopamine and AKT-mediated signaling.
19. Beaulieu J.M., Tirotta E., Sotnikova T.D., Masri B., Salahpour A., Gainetdinov R.R., Borrelli E., and Caron M.G. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 27 (2007) 881-885. Using dopamine receptor mutants these authors identify D2Rs as major actors in the regulation of the AKT pathway.
20. Bamford N.S., Zhang H., Schmitz Y., Wu N.P., Cepeda C., Levine M.S., Schmauss C., Zakharenko S.S., Zablow L., and Sulzer D. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42 (2004) 653-663. Using optical, electrochemical and electrophysiological approaches, these authors demonstrate that dopamine through a presynaptic D2R-mediated mechanism regulates glutamate release from corticostriatal terminals. This mechanism is proposed to act as a filter to reduce the noise caused by less active terminals.
21. Delle Donne K.T., Sesack S.R., and Pickel V.M. Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum. Brain Res 746 (1997) 239-255
22. Wang Z., Kai L., Day M., Ronesi J., Yin H.H., Ding J., Tkatch T., Lovinger D.M., and Surmeier D.J. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50 (2006) 443-452
23. Surmeier D.J., Ding J., Day M., Wang Z., and Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30 (2007) 228-235
24. Centonze D., Gubellini P., Usiello A., Rossi S., Tscherter A., Bracci E., Erbs E., Tognazzi N., Bernardi G., Pisani A., et al. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience 129 (2004) 157-166
25. Centonze D., Picconi B., Baunez C., Borrelli E., Pisani A., Bernardi G., and Calabresi P. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology 26 (2002) 164-175
26. Dickinson S.D., Sabeti J., Larson G.A., Giardina K., Rubinstein M., Kelly M.A., Grandy D.K., Low M.J., Gerhardt G.A., and Zahniser N.R. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72 (1999) 148-156
27. Rouge-Pont F., Usiello A., Benoit-Marand M., Gonon F., Piazza P.V., and Borrelli E. Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci 22 (2002) 3293-3301
28. Benoit-Marand M., Borrelli E., and Gonon F. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J Neurosci 21 (2001) 9134-9141
29. Schmitz Y., Schmauss C., and Sulzer D. Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J Neurosci 22 (2002) 8002-8009
30. Rouge-Pont F., Piazza P.V., Kharouby M., Le Moal M., and Simon H. Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study. Brain Res 602 (1993) 169-174
31. Hooks M.S., Jones G.H., Juncos J.L., Neill D.B., and Justice J.B. Individual differences in schedule-induced and conditioned behaviors. Behav Brain Res 60 (1994) 199-209
32. Marinelli M., and White F.J. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 20 (2000) 8876-8885
33. Bolan E.A., Kivell B., Jaligam V., Oz M., Jayanthi L.D., Han Y., Sen N., Urizar E., Gomes I., Devi L.A., et al. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 71 (2007) 1222-1232
34. Lee F.J., Pei L., Moszczynska A., Vukusic B., Fletcher P.J., and Liu F. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. Embo J 26 (2007) 2127-2136. This article reports for the first time an association between D2Rs and DAT, which modulates DAT activity and dopamine concentration at the synapse.
35. Gainetdinov R.R., and Caron M.G. Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43 (2003) 261-284
36. Konradi C. The molecular basis of dopamine and glutamate interactions in the striatum. Adv Pharmacol 42 (1998) 729-733
37. Valjent E., Pascoli V., Svenningsson P., Paul S., Enslen H., Corvol J.C., Stipanovich A., Caboche J., Lombroso P.J., Nairn A.C., et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A 102 (2005) 491-496
38. Xu M., Hu X.T., Cooper D.C., Moratalla R., Graybiel A.M., White F.J., and Tonegawa S. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79 (1994) 945-955
39. Bertran-Gonzalez J., Bosch C., Maroteaux M., Matamales M., Herve D., Valjent E., and Girault J.A. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28 (2008) 5671-5685. Using newly generated mice expressing fluorescent proteins under the control of the dopamine D1R or D2R promoters, these authors perform an elegant analysis of the molecular response to cocaine and haloperidol in vivo. The results show that acute cocaine activates mostly D1R-expressing MSNs sparing D2R-expressing cells.
40. Welter M., Vallone D., Samad T.A., Meziane H., Usiello A., and Borrelli E. Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine. Proc Natl Acad Sci U S A 104 (2007) 6840-6845. Using D2R-/- and D2L-/- mice, these authors show that the motor and cellular responses to cocaine are severely impaired in the absence of both isoforms of the D2R. These unexpected results suggest that D2R-mediated signaling exert an inhibitory effect on yet to determine brain circuitries. Importantly, the presence of only D2S, as in D2L-/- mice, is able to restore a normal response most probably through preserved presynaptic functions.
41. Kelly M.A., Rubinstein M., Phillips T.J., Lessov C.N., Burkhart-Kasch S., Zhang G., Bunzow J.R., Fang Y., Gerhardt G.A., Grandy D.K., et al. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18 (1998) 3470-3479
42. Chausmer A.L., Elmer G.I., Rubinstein M., Low M.J., Grandy D.K., and Katz J.L. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice. Psychopharmacology (Berl) 163 (2002) 54-61
43. Liu X.Y., Chu X.P., Mao L.M., Wang M., Lan H.X., Li M.H., Zhang G.C., Parelkar N.K., Fibuch E.E., Haines M., et al. Modulation of D2R-NR2B interactions in response to cocaine. Neuron 52 (2006) 897-909
44. Caine S.B., Negus S.S., Mello N.K., Patel S., Bristow L., Kulagowski J., Vallone D., Saiardi A., and Borrelli E. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 22 (2002) 2977-2988
45. Rocha B.A., Fumagalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., Miller G.W., and Caron M.G. Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1 (1998) 132-137
46. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., and Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388 (1997) 586-589
47. Elmer G.I., Pieper J.O., Rubinstein M., Low M.J., Grandy D.K., and Wise R.A. Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J Neurosci 22 (2002) RC224
48. Elmer G.I., Pieper J.O., Levy J., Rubinstein M., Low M.J., Grandy D.K., and Wise R.A. Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice. Psychopharmacology (Berl) 182 (2005) 33-44
49. Phillips T.J., Brown K.J., Burkhart-Kasch S., Wenger C.D., Kelly M.A., Rubinstein M., Grandy D.K., and Low M.J. Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci 1 (1998) 610-615
50. Risinger F.O., Freeman P.A., Rubinstein M., Low M.J., and Grandy D.K. Lack of operant ethanol self-administration in dopamine D2 receptor knockout mice. Psychopharmacology (Berl) 152 (2000) 343-350
51. Cepeda C., Hurst R.S., Altemus K.L., Flores-Hernandez J., Calvert C.R., Jokel E.S., Grandy D.K., Low M.J., Rubinstein M., Ariano M.A., et al. Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol 85 (2001) 659-670
52. Chesselet M.F., Plotkin J.L., Wu N., and Levine M.S. Development of striatal fast-spiking GABAergic interneurons. Prog Brain Res 160 (2007) 261-272
53. Tirotta E., Fontaine V., Picetti R., Lombardi M., Samad T.A., Oulad-Abdelghani M., Edwards R., and Borrelli E. Signaling by dopamine regulates D2 receptors trafficking at the membrane. Cell Cycle 7 (2008) 2241-2248